Peripheral κ1-opioid receptor-mediated analgesia in mice

European Journal of Pharmacology

Volumn 310, Issue 2-3, 1996, Pages 141-143

  Kolesnikov, Yuri ^a,b   Jain, Subhash ^b   Wilson, Roger ^b   Pasternak, Gavril W ^a,b  

^a Box 226   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Analgesia, peripheral; Tail flick assay; Opioid receptor

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL GANGLION; TAIL FLICK TEST;

EID: 0030605969     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00520-1     Document Type: Article

References (15)

1. Adams, J.U., X. Chen, J.K. Deriel, M.W. Adler and L.-Y. Liu-Chen, 1994. Inlracerebroventricular treatment with an antisense oligodeoxynucleotide to kappa-opioid receptors inhibited kappa-agonist-induced analgesia in rats, Brain Res. 667, 129.
2. Barber, A. and R. Gottschlich, 1992, Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation, Med. Res. Rev. 12, 525.
3. Chien, C.-C., G. Brown, Y.-X. Pan and G.W. Pasternak, 1994. Blockade of U50.488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor, Eur. J. Pharmacol. 253, R7.
4. Fields, H.L., P.C. Emson, B.K. Leigh, R.F.T. Gilbert and L.L. Iversen, 1980. Multiple opiate receptor sites on primary afferent fibres, Nature 284, 351.
5. Hassan, A.H.S., A. Ableitner, C. Stein and A. Herz, 1993, Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue, Neuroscience 55, 185.
6. Hylden, J.L.K. and G.L. Wilcox, 1980, Intrathecal morphine in mice: a new technique, Eur. J. Pharmacol. 67, 313.
7. Joris, J.L., R. Dubner and K.M. Hargreaves, 1987, Opioid analgesia at peripheral sites: a target for opioids released during stress and inflammation?, Anesth. Analg. 66, 1277.
8. Junien, J.L. and J.G. Weitstem, 1992. Role of opioids in peripheral analgesia, Life Sci. 51, 2009.
9. Pasternak, G.W., 1993. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16, 1.
10. Pick, C.G., J. Cheng, D. Paul and G.W. Pasternak, 1991, Genetic influences in opioid analgesic sensitivity in mice, Brain Res. 556, 295.
11. Stein, C., 1993. Peripheral mechanisms of opioid analgesia, Anesth. Analg. 76, 182.
12. Stein, C., 1995. Mechanisms of disease: the control of pain in peripheral tissue by opioids. New Engl. J. Med. 332, 1685.
13. Umans, J.G. and C.E. Inturrisi, 1981, Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice, J. Pharmacol. Exp. Ther. 218, 409.
14. Von Voigtlander, P.P., R.A. Lahti and J.H. Ludens, 1983, U50,488: a selective and structurally novel non-mu (kappa) opioid agonist, J. Pharmacol. Exp. Ther. 224, 7.
15. Yee, F., H. Ericson, D.J. Reis and C. Wahlestedt, 1994, Cellular uptake of intracerebroventricularly administered biotin-or digoxigenin-labeled antisense oligodeoxynucleotides in the rat, Cell. Mol. Neurobiol. 14, 475.